Your browser doesn't support javascript.
loading
The past, present and future of anti-malarial medicines.
Tse, Edwin G; Korsik, Marat; Todd, Matthew H.
Afiliação
  • Tse EG; School of Chemistry, The University of Sydney, Sydney, NSW, 2006, Australia. etse6978@uni.sydney.edu.au.
  • Korsik M; School of Chemistry, The University of Sydney, Sydney, NSW, 2006, Australia.
  • Todd MH; School of Chemistry, The University of Sydney, Sydney, NSW, 2006, Australia. matthew.todd@ucl.ac.uk.
Malar J ; 18(1): 93, 2019 Mar 22.
Article em En | MEDLINE | ID: mdl-30902052
ABSTRACT
Great progress has been made in recent years to reduce the high level of suffering caused by malaria worldwide. Notably, the use of insecticide-treated mosquito nets for malaria prevention and the use of artemisinin-based combination therapy (ACT) for malaria treatment have made a significant impact. Nevertheless, the development of resistance to the past and present anti-malarial drugs highlights the need for continued research to stay one step ahead. New drugs are needed, particularly those with new mechanisms of action. Here the range of anti-malarial medicines developed over the years are reviewed, beginning with the discovery of quinine in the early 1800s, through to modern day ACT and the recently-approved tafenoquine. A number of new potential anti-malarial drugs currently in development are outlined, along with a description of the hit to lead campaign from which it originated. Finally, promising novel mechanisms of action for these and future anti-malarial medicines are outlined.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Malária / Antimaláricos Limite: Humans Idioma: En Ano de publicação: 2019 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Malária / Antimaláricos Limite: Humans Idioma: En Ano de publicação: 2019 Tipo de documento: Article